These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9324177)

  • 61. Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil.
    Gwilt P; Tempero M; Kremer A; Connolly M; Ding C
    Cancer Chemother Pharmacol; 2000; 45(3):247-51. PubMed ID: 10663643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin.
    Stein TA; Burns GP; Bailey B; Citron ML
    Cancer Invest; 1994; 12(4):375-8. PubMed ID: 8032956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics of fluorouracil in humans.
    MacMillan WE; Wolberg WH; Welling PG
    Cancer Res; 1978 Oct; 38(10):3479-82. PubMed ID: 688233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration.
    Campora E; Esposito M; Civalleri D; Gogioso L; Decian F; Balletto N; Falcone A; Nobile MT; Parodi B; Cafaggi S
    Anticancer Res; 1987; 7(4B):829-32. PubMed ID: 3674768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
    Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.
    Presant CA; Wolf W; Waluch V; Wiseman CL; Weitz I; Shani J
    J Clin Oncol; 2000 Jan; 18(2):255-61. PubMed ID: 10637237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients.
    Chan TC; Coppoc GL; Zimm S; Cleary S; Howell SB
    Cancer Res; 1988 Jan; 48(1):215-8. PubMed ID: 3334996
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The relationship between plasma pharmacokinetics and tissue metabolites of 5-fluorouracil (5-FU) in patients with colorectal cancer.
    Finan PJ; Chisholm EM; Woodhouse L; Giles GR
    Eur J Surg Oncol; 1987 Aug; 13(4):349-53. PubMed ID: 2957234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.
    Finj C; Sadée W
    Cancer Chemother Rep; 1975; 59(2 Pt 1):279-86. PubMed ID: 1097091
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats.
    Kobuchi S; Ito Y; Hayakawa T; Nishimura A; Shibata N; Takada K; Sakaeda T
    J Pharmacol Toxicol Methods; 2014; 70(2):134-44. PubMed ID: 25072509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Disposition of 5-fluorouracil after intravenous bolus doses of a commercial formulation to cancer patients.
    Sitar DS; Shaw DH; Thirlwell MP; Ruedy JR
    Cancer Res; 1977 Nov; 37(11):3981-4. PubMed ID: 908036
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of whole body hyperthermia on 5-fluorouracil pharmacokinetics in vivo and clonogenicity of mammalian colon cancer cells.
    Lange J; Zänker KS; Siewert JR; Blümel G; Eisler K; Kolb E
    Anticancer Res; 1984; 4(1-2):27-31. PubMed ID: 6712174
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pharmacokinetic studies of continuous and bolus intraportal 5-fluorouracil infusion].
    Hanai A; Yamamura T; Matsuzaki H; Oikawa H; Kikuchi K; Ozasa T; Akaishi O; Senda T; Katayama K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1536-9. PubMed ID: 1530302
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography.
    Ackland SP; Garg MB; Dunstan RH
    Anal Biochem; 1997 Mar; 246(1):79-85. PubMed ID: 9056186
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics of intrapericardial administration of 5-fluorouracil.
    Lerner-Tung MB; Chang AY; Ong LS; Kreiser D
    Cancer Chemother Pharmacol; 1997; 40(4):318-20. PubMed ID: 9225949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacometric analysis of the effect of furosemide on suramin pharmacokinetics.
    Piscitelli SC; Forrest A; Lush RM; Ryan N; Whitfield LR; Figg WD
    Pharmacotherapy; 1997; 17(3):431-7. PubMed ID: 9165547
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes.
    van Griensven JM; Jusko WJ; Lemkes HH; Kroon R; Verhorst CJ; Chiang ST; Cohen AF
    Clin Pharmacol Ther; 1995 Dec; 58(6):631-40. PubMed ID: 8529328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferon-alpha.
    Findlay MP; Raynaud F; Cunningham D; Iveson A; Collins DJ; Leach MO
    Ann Oncol; 1996 Jan; 7(1):47-53. PubMed ID: 9081391
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A retrospective analysis of plasma concentration monitoring of fluorouracil in patients with advanced colorectal cancer.
    Yang Q; Bi Y; Li X; Liu Q; Ma J; Zhang C; Zhang J; He G
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e36-e40. PubMed ID: 32296503
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An immunoassay method for the pharmacokinetics of 5-fluorouracil in patients with gastric cancer administered adjuvant chemotherapy.
    Matsumoto H; Higashida M; Kubota H; Murakami H; Tsutsumi K; Nakashima H; Oka Y; Okumura H; Nakamura M; Hirai T
    Anticancer Res; 2012 Nov; 32(11):5111-4. PubMed ID: 23155289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.